Evidence map›Paper›PMID 18435418›Full record

ArticleSynapse (New York, N.Y.)2008

Possible dopaminergic stimulation of locus coeruleus alpha1-adrenoceptors involved in behavioral activation.

Yan Lin, David Quartermain, Adrian J Dunn, David Weinshenker, Eric A Stone

Open access · greenAbstract read
In one paragraph

Article in Synapse (New York, N.Y.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. αFrontiers in pharmacology · 2020
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Cross interaction of dopaminergic and adrenergic systems in neural modulation.International journal of physiology, pathophysiology and pharmacology · 2014
    Review
  12. Article
  13. Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Review
  14. α-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yan LinDepartment of Psychiatry, New York University School of Medicine, New York, New York 10016, USA.
David Quartermain
Adrian J Dunn
David Weinshenker
Eric A Stone
New York University · USEmory University · USUniversity of Hawaii System · US

Funding

REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSIONR01MH045265 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STONE, ERIC A · 2000 to 2010
$3.1M
CRF-Norepinephrine Interactions in Stress and DepressionR01MH050947 · NIMH · UNIVERSITY OF HAWAII AT MANOA · PI DUNN, ADRIAN JOHN · 1995 to 2008
$1.4M
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSIONR37MH045265 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STONE, ERIC A · 1989 to 1996
–
NIMH NIH HHS MH45265NIMH NIH HHS MH50947NIMH NIH HHS R01 MH045265NIMH NIH HHS R01 MH050947NIMH NIH HHS R37 MH045265
6 · The paper itself

Abstract

alpha(1)-Adrenoceptors of the locus coeruleus (LC) have been implicated in behavioral activation in novel surroundings, but the endogenous agonist that activates these receptors has not been established. In addition to the canonical activation of alpha(1)-receptors by norepinephrine (NE), there is evidence that dopamine (DA) may also activate certain brain alpha(1)-receptors. This study examined the contribution of DA to exploratory activity in a novel cage by determining the effect of infusion of various dopaminergic and adrenergic drugs into the mouse LC. It was found that the D2/D3 agonist, quinpirole, which selectively blocks the release of CNS DA, produced a dose-dependent and virtually complete abolition of exploration and all movement in the novel cage test. The quinpirole-induced inactivity was significantly attenuated by coinfusion of DA but not by the D1 agonist, SKF38390. Furthermore, the DA attenuation of quinpirole inactivity was blocked by coinfusion of the alpha(1)-adrenergic receptor antagonist, terazosin, but not by the D1 receptor antagonist, SCH23390. LC infusions of either quinpirole or terazosin also produced profound inactivity in DA-beta-hydroxylase knockout (Dbh -/-) mice that lack NE, indicating that their behavioral effects were not due to an alteration of the release or action of LC NE. Measurement of endogenous DA, NE, and 5HT and their metabolites in the LC during exposure to the novel cage indicated an increase in the turnover of DA and NE but not 5HT. These results indicate that DA is a candidate as an endogenous agonist for behaviorally activating LC alpha(1)-receptors and may play a role in the activation of this nucleus by novel surroundings.

Indexed as

Adrenergic alpha-1 Receptor AgonistsAnimalsArousalDopamineDopamine AgonistsDopamine AntagonistsDopamine beta-HydroxylaseDose-Response Relationship, DrugDrug InteractionsExploratory BehaviorFemaleLocus CoeruleusMaleMiceMice, Inbred C57BLMice, KnockoutAdrenergic alpha-1 Receptor AgonistsDopamineDopamine AgonistsDopamine AntagonistsDopamine beta-HydroxylaseNorepinephrineReceptors, Adrenergic, alpha-1Serotonin

Identifiers

PMID18435418
PMCPMC2754581
OpenAlexW2032547565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.